Allwormer Chew for Medium and Large Dogs

Overview
PURINA Totalcare® Allwormer Tablets are an oral dewormer formulated to control the major intestinal worms found in dogs — including roundworms, hookworms, whipworms and tapeworms (including hydatid tapeworm). The tablets contain oxibendazole and praziquantel, which work together to target a broad range of intestinal parasites.
Suitable for medium and large dogs, this product forms part of PURINA® worm-control range and supports routine intestinal parasite management when used as directed.
Ingredients
Active: Oxibendazole, Praziquantel. Inactive: Not publicly documented.
This product is marketed as a liver flavoured tablet, however Purina Australia has not publicly disclosed the excipient list for Totalcare Allwormer.

Oxibendazole is a broad-spectrum anthelmintic used to treat intestinal worm infections in dogs. It kills roundworms, hookworms, and whipworms by inhibiting their ability to absorb nutrients, leading to parasite death.

Praziquantel is an antiparasitic drug widely used to treat tapeworm infections in dogs. It works by causing severe spasms and paralysis in tapeworms, allowing them to be digested and eliminated from the body.
Unknown ingredients refer to components listed in pet food formulations whose specific identity or source is not disclosed. These may originate from animal, plant, or synthetic sources. Their primary purpose can vary, including nutritional supplementation or functional roles such as preservation. As their exact form is unspecified, it is unclear whether they are used in their natural state or as processed compounds, raising concerns about transparency and traceability.
This ingredient is included as a cost-effective component or processing aid, potentially serving to optimise manufacturing efficiency or product texture. Its presence may also support labelling requirements or contribute to the product’s stability, though its specific functional role is not clearly defined.
.png)





















Comments
0 comments
Login to Join the Conversation 💬